Search

everythinglearnresearchcommunity

for

Search:↓

Research 10 of 399

1. The Cutaneous Side Effects of Selective BRAF Inhibitors and Anti-CTLA4 Agents: the Growing Role of the Dermatologist in the Management of Patients with Metastatic Melanoma Current Dermatology Reports · 2013 · 6 citations
2. ODP342 Panhypopituitarism Induced by CTLA-4 and PD-1/PD-L1 Inhibitor Immunotherapy Journal of the Endocrine Society · 2022
3. Immune-related alopecia (areata and universalis) in cancer patients receiving immune checkpoint inhibitors 2016 · 87 citations
4. IMMUNE-RELATED SKIN TOXICITIES TO CHECKPOINT INHIBITORS THERAPY Голова и шея. · 2022
5. An In Situ Chemotherapy Drug Combined with Immune Checkpoint Inhibitor for Chemoimmunotherapy Nanomaterials · 2023 · 1 citations
6. Cutaneous Side Effects of Modern Targeted Therapy and Immunotherapy in Patients with Dermatological Malignancies Cancers · 2023
7. The Influence of Flightless I: Regeneration versus Wound Healing Journal of Investigative Dermatology · 2011 · 1 citations
8. Dermatologic adverse events associated with chemotherapy and targeted anticancer therapy Dermatology Review · 2016 · 4 citations
9. Clinical and Genetic Aspects of Alopecia Areata: A Cutting Edge Review Genes · 2023 · 1 citations
10. Taiwanese Dermatological Association consensus on the diagnosis and management of alopecia areata Dermatologica Sinica · 2025 · 4 citations

Community

— no results